Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Assets: 2022-2023

Historic Assets for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $266.2 million.

  • Therapeutics' Assets fell 20.49% to $266.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $266.2 million, marking a year-over-year decrease of 20.49%. This contributed to the annual value of $321.9 million for FY2022, which is N/A change from last year.
  • Per Therapeutics' latest filing, its Assets stood at $266.2 million for Q3 2023, which was down 7.25% from $287.0 million recorded in Q2 2023.
  • Therapeutics' 5-year Assets high stood at $378.6 million for Q1 2022, and its period low was $266.2 million during Q3 2023.
  • For the 2-year period, Therapeutics' Assets averaged around $321.8 million, with its median value being $321.9 million (2022).
  • Data for Therapeutics' Assets shows a maximum YoY dropped of 20.49% (in 2023) over the last 5 years.
  • Therapeutics' Assets (Quarterly) stood at $321.9 million in 2022, then fell by 20.49% to $266.2 million in 2023.
  • Its Assets stands at $266.2 million for Q3 2023, versus $287.0 million for Q2 2023 and $310.0 million for Q1 2023.